Adhera Therapeutics, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
on January 12, 2024, the Company received notice from Zahed Subhan that he was resigning as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors.
he was resigning from the Company’s Board of Directors effective January 12, 2024.
Extracted from this filing and checked against the source text.
Zahed Subhan resigned as Chief Executive Officer at Adhera Therapeutics, Inc..
on January 12, 2024, the Company received notice from Zahed Subhan that he was resigning as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors.View on SEC.gov
Trond K. Waerness resigned as Director at Adhera Therapeutics, Inc..
he was resigning from the Company’s Board of Directors effective January 12, 2024.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.